Skip to main content
Premium Trial:

Request an Annual Quote

Agendia to Use Rubicon's WGA Kits in Breast Cancer Dx Tests

Premium

Agendia will use Rubicon Genomics' whole-genome RNA amplification technology in its breast cancer diagnostic tests, Rubicon said today.

Under a clinical supply agreement, Agendia will apply Rubicon's TransPlex technology to analyze formalin-fixed, paraffin-embedded patient samples on Agendia's Symphony suite of breast cancer diagnostics.

RNA or DNA extracted from FFPE samples is highly fragmented and often contains only small amounts of usable DNA or RNA, which may be insufficient for analysis. Rubicon's TransPlex and GenomePlex amplification kits are members of Rubicon's OmniPlex family of technologies, and have been shown to be able to overcome these problems and deliver sufficient quantities of high-quality nucleic acids to enable accurate and consistent analyses, the company said.

In a statement, Rubicon CEO James Koziarz called the deal an important milestone for his firm. "This supply agreement with cancer diagnostics pioneer Agendia represents our first large-scale commercial partnership with a provider of clinical diagnostic tests, and we expect it to be the first of many going forward," he said.

Financial and other terms of the deal were not disclosed.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.